Overview
- 4 FDA inspections are on record.
- 3 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-09-05.
At a glance
Inspections
4
Form 483s
3
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 18 Aug 2025 – 5 Sep 2025 | Human Drugs | 483 | View 483 → |
| 21 Jun 2023 – 31 Jul 2023 | Human Drugs | 483 | View 483 → |
| 14 Feb 2022 – 25 Feb 2022 | Human Drugs | 483 | View 483 → |
| 15 Apr 2019 – 26 Apr 2019 | Human Drugs | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
5 Sep 2025
21 CFR 211.160(a)
Following/documenting laboratory controls
Cited by Roger F Zabinski, Homero W Aguilar
5 Sep 2025
21 CFR 211.192
Investigations of discrepancies, failures
Cited by Roger F Zabinski, Homero W Aguilar
5 Sep 2025
21 CFR 211.192
Written record of investigation incomplete
Cited by Roger F Zabinski, Homero W Aguilar
5 Sep 2025
21 CFR 211.22(d)
Procedures not in writing, fully followed
Cited by Roger F Zabinski, Homero W Aguilar
Investigators
FDA investigators tied to this site in the record.
Roger F Zabinski1 insp.
Homero W Aguilar1 insp.
June P Page1 insp.
Melinda Lee1 insp.
Mary-Jeanet Mcgarry1 insp.
Dogbeda F Mackenzie1 insp.
Christopher M Jenner1 insp.
Gunneet Kaur1 insp.
Bryan L Mcguckin1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 5x |
| 21 CFR 211.113(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.165(e) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.42(c)(10)(iv) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.42(c)(10)(vi) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.68(b) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.84(d)(2) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.100(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.100(b) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.130 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(b)(3) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.160(b)(4) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.166(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.188 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.194(a)(5) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.56(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.67(a) | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 310.305(c) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Central Admixture Pharmacy Services, Inc.'s 3 Form 483s
Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat